{
    "nctId": "NCT00291135",
    "briefTitle": "Protocol for Women at Increased Risk of Developing Breast Cancer",
    "officialTitle": "Study of the Effect of Letrozole on Breast Biomarkers of High Risk Postmenopausal Women Receiving Hormone Replacement Therapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 42,
    "primaryOutcomeMeasure": "Change in Proliferation of Breast Epithelial Cells Obtained by Random Periareolar Fine Needle Aspiration.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* evidence of hyperplasia with/without atypia upon random periareolar fine needle aspiration of breast\n* on hormone replacement therapy\n* postmenopausal\n* increased risk of developing breast cancer based on personal or family history\n* never have taken aromatase inhibitors or selective estrogen receptor modulators in last six months\n* women who have a high risk of breast cancer\n* older than 18 years\n\nExclusion Criteria:\n\n* anticoagulants\n* marked breast tenderness\n* pregnant or within twelve months of breast feeding/childbirth",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}